CAT
Caterpillar Inc.
CAT has the edge over RHI overall, supported by stronger fundamentals and stronger modeled upside.
RHI
Robert Half International Inc.
RHI's outlook is improving despite an expensive valuation.
CAT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Strong | |
| Strong |
CAT's revenue, profitability, cash flow and balance sheet are all currently healthy.
RHI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Stable | |
| Strong |
RHI's balance sheet is currently strong, and its revenue, profitability and cash flow are stable.
CAT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $380 | -37% |
| Fair | 18x | $461 | -24% |
| Forward | 20x | $605 | — |
| Current | 24x | $605 | — |
| Expensive | 33x | $840 | +39% |
Historical ranges are pointers, not guarantees.
CAT has the edge over RHI in the historical PE scenario, which offers more potential upside but is not a forecast.
RHI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 13x | $16.07 | -62% |
| Fair | 19x | $23.38 | -44% |
| Forward | 24x | $41.97 | — |
| Expensive | 26x | $31.30 | -25% |
| Current | 35x | $41.97 | — |
Historical ranges are pointers, not guarantees.
RHI's PE is in its expensive range at 35x. If earnings grow as analysts expect, today's price would be 24x next year's earnings.
CAT Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Moderate | |
| Low |
CAT has the edge over RHI on the outlook, with more favorable revenue expectations.
RHI Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Limited | |
| Moderate |
Analysts expect RHI's earnings to grow and its profitability to improve, with its revenue holding steady.
CAT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $30.32 | +19% |
| Q3 2026 | $25.48 | +31% |
| Q2 2026 | $23.23 | +18% |
| Q1 2026 | $20.08 | -2% |
| Q4 2025 | $18.81 | -15% |
| Q3 2025 | $19.46 | -9.7% |
| Q2 2025 | $19.64 | -10% |
| Q1 2025 | $20.50 | -7.4% |
| Q4 2024 | $22.05 | +9.6% |
CAT has the edge over RHI on earnings, with more consistent year-over-year improvement.
RHI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.78 | +47% |
| Q3 2026 | $1.21 | -21% |
| Q2 2026 | $1.15 | -34% |
| Q1 2026 | $1.30 | -35% |
| Q4 2025 | $1.33 | -45% |
| Q3 2025 | $1.54 | -44% |
| Q2 2025 | $1.75 | -42% |
| Q1 2025 | $2.00 | -40% |
| Q4 2024 | $2.44 | -37% |
RHI's earnings per share have fallen from their peak: $1.21 over the past year, against $6.17 in mid-2022.
CAT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $20.7B | +17% |
| Q2 2026 | $20.5B | +24% |
| Q1 2026 | $17.4B | +22% |
| Q4 2025 | $19.1B | +18% |
| Q3 2025 | $17.6B | +9.5% |
| Q2 2025 | $16.6B | -0.7% |
| Q1 2025 | $14.2B | -9.8% |
| Q4 2024 | $16.2B | -5% |
CAT has the edge over RHI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 20% | +3.1 points |
| Q2 2026 | 21% | +3.6 points |
| Q1 2026 | 18% | -0.4 points |
| Q4 2025 | 14% | -4.1 points |
| Q3 2025 | 17% | -2.2 points |
| Q2 2025 | 17% | -3.6 points |
| Q1 2025 | 18% | -4.2 points |
| Q4 2024 | 18% | -0.3 points |
CAT has the edge over RHI on profitability, with a higher operating margin.
RHI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.4B | +0.4% |
| Q2 2026 | $1.3B | -2.4% |
| Q1 2026 | $1.3B | -3.8% |
| Q4 2025 | $1.3B | -5.8% |
| Q3 2025 | $1.4B | -7.5% |
| Q2 2025 | $1.4B | -7% |
| Q1 2025 | $1.4B | -8.4% |
| Q4 2024 | $1.4B | -6.1% |
RHI's revenue fell from its 2022 peak and has held roughly level since: $1.4B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.5% | +4.5 points |
| Q2 2026 | -4.7% | -4.8 points |
| Q1 2026 | 2.8% | 0 points |
| Q4 2025 | 1.7% | -3.4 points |
| Q3 2025 | 1% | -5.2 points |
| Q2 2025 | 0.1% | -6.1 points |
| Q1 2025 | 2.9% | -2.9 points |
| Q4 2024 | 5.1% | -2.7 points |
RHI's operating margin was 5.5% last quarter, up 4.5 points from the same quarter a year ago.
CAT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $3.7B | +19% |
| Q2 2026 | $3.8B | +47% |
| Q1 2026 | $1.1B | +97% |
| Q4 2025 | $2.7B | +0.1% |
| Q3 2025 | $3.1B | -1.5% |
| Q2 2025 | $2.6B | -4.2% |
| Q1 2025 | $579M | -63% |
| Q4 2024 | $2.7B | -22% |
CAT has the edge over RHI on cash flow, with more consistent year-over-year improvement.
RHI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $57.7M | -9.2% |
| Q2 2026 | $101.5M | -2.5% |
| Q1 2026 | -$120.8M | -$49.1M |
| Q4 2025 | $170.8M | +22% |
| Q3 2025 | $63.6M | -43% |
| Q2 2025 | $104.2M | -20% |
| Q1 2025 | -$71.7M | -$44M |
| Q4 2024 | $140.5M | +37% |
RHI still generates free cash flow, though less than at its 2020 peak: $209M over the past year.
CAT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -1.6M shares |
| 1 year | -2.1% | -9.9M shares |
| 3 years | -10% | -51.7M shares |
| 5 years | -16% | -86.7M shares |
| Available history | -19% | -107M shares |
CAT has the edge over RHI on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2B |
| Q2 2026 | $1.5B |
| Q1 2026 | $5B |
| Q4 2025 | $340M |
| Q3 2025 | $362M |
| Q2 2025 | $828M |
| Q1 2025 | $3.7B |
| Q4 2024 | $640M |
CAT spent $8.1B buying back its own shares over the past year, up 47% from the year before.
RHI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.6% | +633K shares |
| 1 year | +0.9% | +899K shares |
| 3 years | -4.6% | -4.9M shares |
| 5 years | -9.5% | -10.6M shares |
| Available history | -13% | -15.5M shares |
RHI has 101M diluted shares, up 0.9% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $33,000 |
| Q2 2026 | $618,000 |
| Q1 2026 | $6.1M |
| Q4 2025 | $24,000 |
| Q3 2025 | $21.1M |
| Q2 2025 | $21.1M |
| Q1 2025 | $49.9M |
| Q4 2024 | $80.5M |
RHI spent $7M buying back its own shares over the past year, down 96% from the year before.
CAT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.5x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.3x | Net Cash |
| Q4 2025 | 2.0x | Healthy |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q1 2025 | -0.3x | Net Cash |
| Q4 2024 | 1.6x | Healthy |
CAT has more cash than debt.
RHI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -2.6x | Net Cash |
| Q2 2026 | -5.3x | Net Cash |
| Q1 2026 | -2.2x | Net Cash |
| Q4 2025 | -3.6x | Net Cash |
| Q3 2025 | -2.1x | Net Cash |
| Q2 2025 | -1.5x | Net Cash |
| Q1 2025 | -1.0x | Net Cash |
| Q4 2024 | -1.4x | Net Cash |
RHI has the edge over CAT on leverage, with a lower net debt burden relative to earnings.
CAT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.7 | Neutral |
| Stochastic | 6.7 | Oversold |
CAT's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
RHI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.3 | Neutral |
| Stochastic | 68.9 | Neutral |
RHI's weekly RSI is 57 (neutral) and its Stochastic is 69 (neutral).
CAT PE vs Industrials Sector
| Metric | CAT | Sector median | Relative |
|---|---|---|---|
| PE | 24x | 24x | 1.3% below |
| PE % | 69 | 58 | 11 pts above |
CAT has the edge over RHI on valuation relative to its sector.
RHI PE vs Industrials Sector
| Metric | RHI | Sector median | Relative |
|---|---|---|---|
| PE | 35x | 24x | 44% above |
| PE % | 98 | 58 | 40 pts above |
RHI is trading at 35x earnings, a 44% premium to the Industrials sector's median of 24x.
CAT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $709.0 | 15% below |
| 20 week MA | $797.0 | 24% below |
| 50 week MA | $771.3 | 22% below |
| 100 week MA | $586.7 | 3.2% above |
| 200 week MA | $443.1 | 37% above |
CAT has pulled back, but its long-term trend is still up: it's below its 8-, 20- and 50-week averages, but 37% above its 200-week average.
RHI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 7% above |
| 20 week MA | $39.4 | 6.5% above |
| 50 week MA | $32.3 | 30% above |
| 100 week MA | $38.8 | 8.1% above |
| 200 week MA | $56.3 | 25% below |
RHI has the edge over CAT on trend strength, trading above more of its moving averages.
CAT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $148.3 | $179.6 | +21% |
| 2021 | $179.6 | $206.2 | +15% |
| 2022 | $206.2 | $239.9 | +16% |
| 2023 | $239.9 | $295.7 | +23% |
| 2024 | $295.7 | $364.9 | +23% |
| 2025 | $364.9 | $583.0 | +60% |
| 2026 YTD | $583.0 | $605.3 | +3.8% |
CAT has finished every year since 2020 higher, and it's up 3.8% so far in 2026.
RHI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $62.4 | $62.2 | -0.4% |
| 2021 | $62.2 | $109.2 | +76% |
| 2022 | $109.2 | $73.4 | -33% |
| 2023 | $73.4 | $87.9 | +20% |
| 2024 | $87.9 | $71.1 | -19% |
| 2025 | $71.1 | $27.7 | -61% |
| 2026 YTD | $27.7 | $42.0 | +51% |
RHI has the edge over CAT on returns for 2026, with the stronger performance.